EDITOR: | November 16th, 2020

Neo Performance Materials Reports Third Quarter 2020 Results

| November 16, 2020 | No Comments
image_pdfimage_print

November 16, 2020 (Source) — Q3 2020 Highlights

SELECTED FINANCIAL RESULTS

TABLE 1: Selected Consolidated Results

Quarter-over-Quarter
Comparison

Year-over-Year
Comparison

Q3 2020

Q3 2019

YTD Q3
2020

YTD Q3
2019

Volume (tonnes)

3,035

3,131

8,883

10,228

($000s)

Revenue

77,864

102,645

236,295

312,911

Operating (loss) income

1,137

8,399

(58,849)

30,488

EBITDA(1)

5,491

12,554

(44,990)

42,722

Adjusted EBITDA(1)

5,730

12,786

16,566

41,276

Adjusted EBITDA %(1)

7.4%

12.5%

7.0%

13.2%

_________________________

(1)Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this news release and in the MD&A.

For the three and nine months ended September 30, 2020, revenues were 24.1% and 24.5% lower, respectively, than in the corresponding periods of 2019.  All three segments experienced significant decreases in revenue as volumes were adversely affected by slower economic activities, largely due to the COVID-19 pandemic.

Neo reported operating income of $1.1 million and net income of $0.4 million for the three months ended September 30, 2020. Operating loss and net loss for the nine months ended September 30, 2020 were mainly from the $59.1 million impairment of assets in the C&O and Rare Metals segments. Operationally, the most significant impact to financial performance is from lower volumes across all three business units, which can largely be attributed to COVID-19 and the corresponding impact to customer demand across the supply chain.  All three business units engaged in various cost-cutting initiatives including shortening shifts, temporarily idling certain facilities, reducing project costs and executing on other working capital reduction initiatives.

Aside from the volume impact from COVID-19, the Magnequench segment saw growth and progress in its strategy to increase magnet-making capability and sales.  The C&O segment saw consistent volumes in the auto-catalyst segment compared to prior year.  A portion of these strong volumes is related to the economic recovery and a portion is related to refilling the supply chain.  The Rare Metals segment saw improved product margins in its Tantalum products, having worked through much of the previous higher-cost inventory that was impacting previous results; however, it was adversely impacted by the decline in Rhenium prices.

Adjusted EBITDA for the three and nine months ended September 30, 2020 was $5.7 million and $16.6 million, respectively; a decrease of $7.1 million and $24.7 million compared to the same periods in 2019.

MAGNEQUENCH SEGMENT RESULTS

TABLE 2: Selected Magnequench Results

Quarter-over-Quarter
Comparison

Year-over-Year
Comparison

Q3 2020

Q3 2019

YTD Q3
2020

YTD Q3
2019

Volume (tonnes)

1,095

1,385

3,390

4,197

($000s)

Revenue

31,620

42,024

100,413

131,052

Operating income

2,965

6,135

11,925

21,780

EBITDA(1)

5,198

8,109

18,567

27,653

Adjusted EBITDA(1)

5,244

8,324

18,524

27,508

_________________________

(1)Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this news release and in the MD&A.

For the three months ended September 30, 2020, Adjusted EBITDA was $5.2 million, a decrease of $3.1 million compared to the same period of the prior year.  For the nine months ended September 30, 2020, Adjusted EBITDA in the Magnequench segment was $18.5 million, compared to $27.5 million in the corresponding period in 2019; a decrease of $9.0 million.  Sales volumes, and their impact on margins and overhead absorption, were the largest contributors to the decrease in Adjusted EBITDA with other impacts including product mix, price reductions, timing of certain operational activities, changes in foreign exchange rates, and timing of pricing pass-through mechanics on material inputs.

For the nine months ended September 30, 2020, volumes in the Magnequench segment were adversely affected by customer shutdowns and slowdowns, primarily as a result of the continued impact of COVID-19. The slowdown of volumes was seen across most applications that utilize Magnequench’s NdFeB magnetic powders.  However, Magnequench saw increases in the production and sales of its NdFeB compression molded (“CM“) magnets, particularly with respect to sales from the NdFeB CM magnet business it purchased in 2019.  The current magnet product line primarily serves laptop computers and consumer electronics and has been on a growth trajectory and has gained market share since the magnet business purchase by Magnequench.  Certain programs and end markets that utilize Magnequench NdFeB powders and CM magnets began to recover in the latter half of the current quarter, partially due to some economic recovery and partially due to supply chains being refilled.  In addition, Magnequench benefited from various cost-cutting initiatives including reducing production shifts at its manufacturing locations.

CHEMICALS & OXIDES (“C&O”) SEGMENT RESULTS

TABLE 3: Selected C&O Results

Quarter-over-Quarter
Comparison

Year-over-Year
Comparison

Q3 2020

Q3 2019

YTD Q3
2020

YTD Q3
2019

Volume (tonnes)

1,929

1,713

5,330

5,901

($000s)

Revenue

36,031

42,469

94,889

124,576

Operating (loss) income

3,145

5,134

(31,629)

15,456

EBITDA(1)

3,908

6,492

(28,132)

19,152

Adjusted EBITDA(1)

3,896

6,543

6,847

18,455

_________________________

(1)Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this news release and in the MD&A.

For the three months ended September 30, 2020, the C&O segment reported operating income of $3.1 million, compared to $5.1 million in the prior year. For the nine months ended September 30, 2020, operating loss of $31.6 million was reported, compared to $15.5 million operating income in the corresponding period in 2019. The operating loss in the nine months ended September 30, 2020 was mainly due to the $35.1 million impairment charge recorded in the second quarter of 2020.

Operationally, for the three months ended September 30, 2020, the C&O segment saw consistent volumes in the auto-catalyst segment compared to prior year, despite the continued impact of COVID-19 and its effect on the automotive end market.  A portion of these strong volumes is related to the economic recovery and a portion is related to refilling the supply chain.  Overall, for the nine months ended September 30, 2020, the C&O auto-catalyst volumes have performed similar to the prior year despite the slowdown in automotive sales.  In the rare earth separation end market, C&O benefited from an increase in the market price of certain products in the latter portion of the quarter.  C&O did not record any meaningful spot sales in the quarter whereas the prior-year periods had significant spot sales.  In the nine-month period ended September 30, 2020, C&O recorded an increase in its SG&A costs related to potential legal costs associated with ongoing patent disputes.  In addition, C&O implemented both cost-cutting initiatives and initiatives to reduce working capital including idling certain production facilities for a period of time.

RARE METALS SEGMENT RESULTS

TABLE 4: Selected Rare Metals Results

Quarter-over-Quarter

Comparison

Year-over-Year

Comparison

Q3 2020

Q3 2019

YTD Q3
2020

YTD Q3
2019

Volume (tonnes)

91

134

323

406

($000s)

Revenue

13,613

22,500

47,592

69,058

Operating (loss)

(892)

(155)

(25,797)

(369)

EBITDA(1)

(179)

946

(22,906)

3,088

Adjusted EBITDA(1)

(179)

963

1,108

3,951

_________________________

(1)Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this news release and in the MD&A.

For the three and nine months ended September 30, 2020, the Rare Metals segment reported operating losses of $0.9 million and $25.8 million, respectively, compared to operating losses of $0.2 million and $0.4 million, respectively, in the corresponding periods in 2019. The operating loss in the nine months ended September 30, 2020 was mainly due to the $24.0 million impairment charge recorded in its second quarter.

Operationally, the Rare Metals segment was impacted by lower volumes and selling prices in the three and nine month periods ended September 30, 2020 compared to the prior year comparable periods.  These lower volumes and selling prices were largely a result of the impact of COVID-19 impacting customer demand and the related supply chains.  This decline was seen across most of the Rare Metals end markets; with the largest end market being aerospace applications.  The Rare Metals segment also recorded idle capacity charges in the quarter as it slowed down production in some facilities that primarily service the aerospace end market.

CONFERENCE CALL ON MONDAY NOVEMBER 16, 2020 AT 10 AM EASTERN

Management will host a teleconference call on Monday, November 16, 2020 at 10:00 a.m. (Eastern Time) to discuss the third quarter 2020 results.  Interested parties may access the teleconference by calling (647) 427-7450 (local) or  (888) 231-8191 (toll-free long distance) or by visiting http://cnw.en.mediaroom.com/events.  A recording of the teleconference may be accessed by calling (416) 849-0833 (local) or (855) 859-2056 (toll-free long distance), and entering pass code 5829209# until December 16, 2020 or by visiting http://cnw.en.mediaroom.com/events.

NON-IFRS MEASURES

This news release refers to certain non-IFRS financial measures such as “Adjusted Net Income”, “EBITDA”, “Adjusted EBITDA”, and “Adjusted EBITDA Margin”.  These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS, and may not be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement IFRS financial measures by providing further understanding of Neo’s results of operations from management’s perspective. Neo’s definitions of non-IFRS measures used in this news release may not be the same as the definitions for such measures used by other companies in their reporting.  Non-IFRS measures have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of Neo’s financial information reported under IFRS.  Neo uses non-IFRS financial measures to provide investors with supplemental measures of its base-line operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures.  Neo believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of issuers.  Neo’s management also uses non-IFRS financial measures in order to facilitate operating performance comparisons from period to period.  For the operating segments, Neo also uses “OIBDA” and “Adjusted OIBDA”, which reconciles to operating income. Neo uses Adjusted OIBDA and Adjusted EBITDA interchangeably as the use of adjustments in each measure provides the same calculated outcome of operating performance. For definitions of how Neo defines such financial measures, please see the “Non-IFRS Financial Measures” section of Neo’s management’s discussion and analysis filing for the three and nine months ended September 30, 2020, available on Neo’s web site at www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 5: CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

($000s)

September 30,
2020

December 31,
2019

ASSETS

Current

Cash and cash equivalents

$

74,616

$

84,735

Restricted cash

4,035

4,185

Accounts receivable

44,654

44,297

Inventories

115,979

112,891

Income taxes receivable

2,182

1,460

Other current assets

12,552

14,230

Total current assets

254,018

261,798

Property, plant and equipment

75,193

94,490

Intangible assets

53,282

65,475

Goodwill

66,989

98,841

Investments

10,067

8,985

Deferred tax assets

2,407

805

Other non-current assets

839

837

Total non-current assets

208,777

269,433

Total assets

$

462,795

$

531,231

LIABILITIES AND EQUITY

Current

Bank advances and other short-term debt

$

74

$

54

Accounts payable and other accrued charges

63,353

56,138

Income taxes payable

2,161

4,756

Provisions

1,871

Lease obligations

1,310

1,660

Derivative liability

11,922

11,833

Other current liabilities

186

85

Total current liabilities

80,877

74,526

Employee benefits

1,828

2,031

Provisions

3,281

5,670

Deferred tax liabilities

13,666

15,894

Lease obligations

2,441

2,953

Other non-current liabilities

1,629

1,524

Total non-current liabilities

22,845

28,072

Total liabilities

103,722

102,598

Non-controlling interest

1,352

3,997

Equity attributable to equity holders of Neo Performance Materials Inc

357,721

424,636

Total equity

359,073

428,633

Total liabilities and equity

$

462,795

$

531,231

See accompanying notes to this table in Neo’s  Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2020, available on Neo’s website at www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 6: CONSOLIDATED RESULTS OF OPERATIONS

Comparison of the three and nine months ended September 30, 2020 to the three and nine months ended September 30, 2019:

($000s)

Three Months Ended
September 30,

Nine Months Ended
September 30,

2020

2019

2020

2019

Revenue

$

77,864

$

102,645

$

236,295

$

312,911

Costs of sales

Costs excluding depreciation and amortization

57,395

74,669

174,824

227,840

Depreciation and amortization

1,996

2,546

7,431

7,309

Gross profit

18,473

25,430

54,040

77,762

Expenses

Selling, general and administrative

10,938

11,383

37,589

29,928

Share-based compensation

973

73

916

377

Depreciation and amortization

1,797

1,971

5,851

5,970

Research and development

3,628

3,604

9,449

9,985

Impairment of assets

59,084

1,014

17,336

17,031

112,889

47,274

Operating income (loss)

1,137

8,399

(58,849)

30,488

Other (expense) income

(92)

129

(65)

(465)

Finance cost, net

(99)

(353)

(3,362)

(2,044)

Foreign exchange loss

(128)

(662)

(440)

(970)

Income (loss) from operations before income taxes and equity income (loss) of associates

818

7,513

(62,716)

27,009

Income tax expense

(1,198)

(3,612)

(811)

(8,807)

(Loss) Income from operations before equity income of associates

(380)

3,901

(63,527)

18,202

Equity income of associates (net of income tax)

781

171

1,082

390

Net income (loss)

$

401

$

4,072

$

(62,445)

$

18,592

Attributable to:

Equity holders of Neo Performance Materials Inc

$

423

$

3,944

$

(60,150)

$

18,281

Non-controlling interest

(22)

128

(2,295)

311

$

401

$

4,072

$

(62,445)

$

18,592

(Loss) Earnings per share attributable to equity holders of Neo Performance Materials Inc.:

Basic

$

0.01

$

0.10

$

(1.60)

$

0.47

Diluted

$

0.01

$

0.10

$

(1.60)

$

0.47

____________________________

See Management’s Discussion and Analysis for the Three and Nine Months Ended September 30, 2020, available on Neo’s website at www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 7: RECONCILIATION OF NET INCOME (LOSS) TO EBITDA, ADJUSTED EBITDA AND FREE CASH FLOW

($000s)

Three Months Ended
September 30,

Nine Months Ended
September 30,

2020

2019

2020

2019

Net income (loss)

$

401

$

4,072

$

(62,445)

$

18,592

Add back (deduct):

Finance cost, net

99

353

3,362

2,044

Income tax expense

1,198

3,612

811

8,807

Depreciation and amortization included in costs of sales

1,996

2,546

7,431

7,309

Depreciation and amortization included in operating expenses

1,797

1,971

5,851

5,970

EBITDA

5,491

12,554

(44,990)

42,722

Adjustments to EBITDA:

Equity income from associates

(781)

(171)

(1,082)

(390)

Other expense (income) (1)

92

(129)

65

465

Foreign exchange loss (2)

128

662

440

970

Impairment of assets (3)

59,084

1,014

Share and value-based compensation (4)

931

153

660

(1,273)

Other non-recurring costs (recoveries) (5)

(131)

(283)

2,389

(2,232)

Adjusted EBITDA

$

5,730

$

12,786

$

16,566

$

41,276

Adjusted EBITDA Margins

7.4%

12.5%

7.0%

13.2%

Less:

Capital expenditures (6)

3,407

12,603

6,436

17,241

Free Cash Flow

2,323

183

10,130

24,035

Free Cash Flow Conversion (7)

40.5%

1.4%

61.1%

58.2%

Notes:

(1)

Represents other expenses resulting from non-operational related activities.  These costs and recoveries are not indicative of Neo’s ongoing activities. 

(2)

Represents unrealized and realized foreign exchange losses (gains) that include non-cash adjustments in translating foreign denominated monetary assets and liabilities.

(3)

The negative economic impacts of COVID-19 were determined to be an impairment indicator as of June 30, 2020 for all Neo’s CGUs.  In accordance with IAS 36 Impairment of Assets, the recoverable amount of Neo’s CGUs was determined based on fair value less cost of disposal for the Magnequench segment and value in use for the C&O and Rare Metals segments. As a result of the impairment test, Neo recognized an impairment charge of $59.1 million as of June 30, 2020, with $35.1 million attributable to the C&O segment and $24.0 million attributable to the Rare Metals segment. No impairment was recorded against the Magnequench segment. In 2019, the $1.0 million impairment in the Rare Metals segment represents impairment of property, plant and equipment and other assets related to the closure of NRM Utah that will not be utilized as a result of the closure.

(4)

Represents share and value-based compensation expense in respect of the Legacy Plan, the LTIP and the long-term value bonus plan, which has similar vesting criteria to the share-based plan and is settled in cash for non-executives and non-North Americans where implementation of a share settlement plan would have been prohibitively expensive in terms of administration and compliance.  Value-based compensation (recovery) of $(42) and $(256) are included in selling, general, and administration expenses for the three and nine months ended September 30, 2020, respectively, expense/(recovery) of $79 and $(1,651) and for the three and nine months ended September 30, 2019, respectively.  Neo has removed both the share and value-based compensation expense from EBITDA to provide comparability with historic periods and to treat it consistently with the share-based awards that they are intended to replace.

(5)

These represents primarily legal, professional advisory fees and other transaction costs incurred/(recovered) with respect to non-operating capital structure related transactions and restructuring costs related to management team changes.  Neo has removed these charges to provide comparability with historic periods.

(6)

Capital expenditures includes $9.7 million related to the assets acquired through a business combination.

(7)

Calculated as Free Cash Flow divided by Adjusted EBITDA.

TABLE 8: RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED NET INCOME (LOSS)

($000s)

Three Months Ended
September 30,

Nine Months Ended
September 30,

2020

2019

2020

2019

Net income (loss) 

$

401

$

4,072

$

(62,445)

$

18,592

Adjustments to net income (loss):

Foreign exchange loss (1)

128

662

440

970

Impairment of assets (2)

59,084

1,014

Share and value-based compensation (3)

931

153

660

(1,273)

Other non-recurring costs (recoveries) (4)

(131)

(283)

2,389

(2,232)

Other items included in other expense (5)

756

Tax impact of the above items

(38)

4

(3,546)

155

Adjusted net income (loss) 

$

1,291

$

4,608

$

(3,418)

$

17,982

Attributable to:

Equity holders of Neo Performance Materials Inc

1,313

4,480

(3,390)

17,671

Non-controlling interest

(22)

128

(28)

311

Weighted average number of common shares outstanding:

Basic

37,610,846

38,522,316

37,671,721

39,117,565

Diluted

37,653,807

38,652,911

37,671,721

39,291,920

Adjusted (loss) earnings per share (6) attributable to equity shareholders of Neo Performance Materials Inc.:

Basic

0.03

0.12

$

(0.09)

$

0.45

Diluted

0.03

0.12

$

(0.09)

$

0.45

Notes:

(1)

Represents unrealized and realized foreign exchange losses (gains) that include non-cash adjustments in translating foreign denominated monetary assets and liabilities.

(2)

The negative economic impacts of COVID-19 were determined to be an impairment indicator as of June 30, 2020 for all Neo’s CGUs.  In accordance with IAS 36 Impairment of Assets, the recoverable amount of Neo’s CGUs was determined based on fair value less cost of disposal for the Magnequench segment and value in use for the C&O and Rare Metals segments. As a result of the impairment test, Neo recognized an impairment charge of $59.1 million as of June 30, 2020, with $35.1 million attributable to the C&O segment and $24.0 million attributable to the Rare Metals segment. No impairment was recorded against the Magnequench segment. In 2019, the $1.0 million impairment in the Rare Metals segment represents impairment of property, plant and equipment and other assets related to the closure of NRM Utah that will not be utilized as a result of the closure.

(3)

Represents share and value-based compensation expense in respect of the Legacy Plan, the LTIP and the long-term value bonus plan, which has similar vesting criteria to the share-based plan and is settled in cash for non-executives and non-North Americans where implementation of a share settlement plan would have been prohibitively expensive in terms of administration and compliance.  Value-based compensation (recovery) of $(42) and $(256) are included in selling, general, and administration expenses for the three and nine months ended September 30, 2020, respectively, expense/(recovery) of $79 and $(1,651) and for the three and nine months ended September 30, 2019, respectively.  Neo has removed both the share and value-based compensation expense from net income to provide comparability with historic periods and to treat it consistently with the share-based awards that they are intended to replace.

(4)

These represents primarily legal, professional advisory fees and other transaction costs incurred/(recovered) with respect to non-operating capital structure related transactions and restructuring costs related to management team changes.  Neo has removed these charges to provide comparability with historic periods.

(5)

Represents certain other transactions that Neo has removed from net income to provide comparability with historic periods.

(6)

Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this new release and in the MD&A, available on Neo’s website www.neomaterials.com and on SEDAR at www.sedar.com.

About Neo Performance Materials

Neo manufactures the building blocks of many modern technologies that enhance efficiency and sustainability.  Neo’s advanced industrial materials – magnetic powders and magnets, specialty chemicals, metals, and alloys – are critical to the performance of many everyday products and emerging technologies. Neo’s products help to deliver the technologies of tomorrow to consumers today.  The business of Neo is organized along three segments: Magnequench, Chemicals & Oxides and Rare Metals. Neo is headquartered in Toronto, Ontario, Canada; with corporate offices in Greenwood Village, Colorado, US; Singapore; and Beijing, China. Neo operates globally with sales and production across 10 countries, being Japan, China, Thailand, Estonia, Singapore, Germany, United Kingdom, Canada, United States, and South Korea. For more information, please visit www.neomaterials.com.

Cautionary Statements Regarding Forward Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws in Canada. Forward-looking information may relate to future events or future performance of Neo. All statements in this release, other than statements of historical facts, with respect to Neo’s objectives and goals, as well as statements with respect to its beliefs, plans, objectives, expectations, anticipations, estimates, and intentions, are forward-looking information. Specific forward-looking statements in this discussion include, but are not limited to, the following: expectations regarding certain of Neo’s future results and information, including, among other things, revenue, expenses, sales growth, capital expenditures, and operations; statements with respect to current and future market trends that may directly or indirectly impact sales and revenue of Neo; expected use of cash balances; continuation of prudent management of working capital; source of funds for ongoing business requirements and capital investments; expectations regarding sufficiency of the allowance for uncollectible accounts and inventory provisions; analysis regarding sensitivity of the business to changes in exchange rates; impact of recently adopted accounting pronouncements; risk factors relating to intellectual property protection and intellectual property litigation; risk factors relating to national or international economies (including the impact of COVID-19), and other risks present in the jurisdictions in which Neo, its customers, its suppliers, and/or its logistics partners operate, and; expectations concerning any remediation efforts to Neo’s design of its internal controls over financial reporting and disclosure controls and procedures. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “continues”, “forecasts”, “projects”, “predicts”, “intends”, “anticipates” or “believes”, or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. Neo believes the expectations reflected in such forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information included in this discussion and analysis should not be unduly relied upon. For more information on Neo, investors should review Neo’s continuous disclosure filings that are available under Neo’s profile at www.sedar.com.

SOURCE Neo Performance Materials, Inc.

For further information: Ali Mahdavi, Investor Relations, (416) 962-3300, Email: a.mahdavi@neomaterials.com; Jim Sims, Media Relations, (303) 503-6203, Email: j.sims@neomaterials.com; Website: www.neomaterials.com

Related Links

www.neomaterials.com